Suntory Pharmaceutical Rsrch is categorized under Medical Labs in Cambridge, MA and active since 2000.
Suntory Pharmaceutical Rsrch was established in 2000, and today employs 1 to 4, earning $10.000.000 to $19.9999.999 per year. This is a Medical Labs business, which does work in the B2C market, and is classified as a Medical Labs, under code number 4242101 by the NAICS.
If you are seeking more information, feel free to contact Frans Stassen, Other at the company’s single location by writing to 1 Kendall Square, Cambridge, Massachusetts MA 02139 or by phoning (617) 583-5300. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Suntory Pharmaceutical Rsrch |
| Contact Person: | Frans Stassen, Other |
| Address: | 1 Kendall Square, Cambridge, Massachusetts 02139 |
| Phone Number: | (617) 583-5300 |
| Annual Revenue (USD): | $10.000.000 to $19.9999.999 |
| Founded: | 2000 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Medical Labs |
| SIC Code: | 8071 |
| NAICS Code: | 4242101 |
| Share This Business: |
Suntory Pharmaceutical Rsrch was started in 2000 to provide professional Medical Labs under the SIC code 8071 and NAICS code 4242101. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $10.000.000 to $19.9999.999 per annum.
Feel free to contact Frans Stassen, Other for inquiries that concern Suntory Pharmaceutical Rsrch by calling the company number (617) 583-5300, as your correspondence is most welcome. Additionally, the physical location of the single location of Suntory Pharmaceutical Rsrch can be found at the coordinates 42.3631,-71.1033 as well as the street address 1 Kendall Square in Cambridge, Massachusetts 02139.
For its online presence, you may visit Suntory Pharmaceutical Rsrch’s website at and engage with its social media outlets through on Twitter and on Facebook.